NCT01689610View on ClinicalTrials.gov

Non-interventional Study With Nab-Paclitaxel (Abraxane®)

CompletedOBSERVATIONAL

Enrollment

705

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

November 30, 2015

Study Completion Date

March 31, 2016

Conditions

Metastatic Breast Cancer

Trial Locations (1)

79108

iOMEDICO AG, Freiburg im Breisgau

All Listed Sponsors

lead

iOMEDICO AG

INDUSTRY

NCT01689610 - Non-interventional Study With Nab-Paclitaxel (Abraxane®) | Biotech Hunter | Biotech Hunter